Search
Research outputs
Response to gefitinib in advanced non-small cell lung cancer patients (NSCLC) with rare epidermal growth factor (EGFR) mutations—serbian experience 2011-2014. [2014]
Zarić, BojanTriptolide promotes degradation of the unfolded gain-of-function Tp53^R175H/Y220C mutant protein by initiating heat shock protein 70 transcription in non-small cell lung cancer
[2022]
Zhou J.; Luo J.; Li P.; Zhou Y.; Li P.; Wang F.; Mallio, Carlo Augusto; Rossi G.; Jalal A.; Filipovic, Nenad
Tian Z.; Zhao X.;
Lung cancer biomarker testing: perspective from Europe [2020]
Thunnissen, Erik; ...; Eri, Zivka; ...; (broj, koautora 21)Response to gefitinib in advanced non-small cell lung cancer patients with rare epidermal growth factor (EGFR) mutations – Serbian experience 2011-2014
[2014]
Radosavljević, Davorin Influence of patient and tumor characteristics on the outcome of gefitinib therapy in advanced lung adenocarcinoma in two centers in Serbia
[2014]
Spasić, Jelena R. Prognostic value of circulating proteins at diagnosis among patients with lung cancer: a comprehensive analysis by smoking status [2024]
Feng, Xiaoshuang; Robbins, Hilary A; Mukeriya, Anush; Foretova, Lenka; Holcatova, Ivana; Janout, Vladimir; Lissowska, Jolanta; Ognjanovic, Miodrag; Swiatkowska, Beata; Zaridze, David;
Brennan, Paul; Johansson, Mattias; Sheikh, Mahdi;
Filters
By type
- 6